John Thomas Dietz Net Worth & Insider Trades
John Thomas Dietz Eiger Biopharmaceuticals, Inc
What is John Thomas Dietz's Net Worth?
The current estimated net worth of Eiger Biopharmaceuticals, Inc's John Thomas Dietz is estimated to be about $189.16K . John Thomas Dietz owns about 21,000 units of Eiger Biopharmaceuticals, Inc common stock. In the last 6 years at Eiger Biopharmaceuticals, Inc, John Thomas Dietz has sold an estimated value of $26.3K worth.
What is John Thomas Dietz's Past Insider Trading?
John Thomas Dietz's largest purchase order was 4,000 units , worth over $55.76K on January 13, 2020. John Thomas Dietz's largest sale order was 22,500 units , worth over $26.3K on December 27, 2022. In total, John Thomas Dietz has made about 13 transactions over 6 years of their time at Eiger Biopharmaceuticals, Inc. John Thomas Dietz usually trades in March, with the busiest year in 2019 and 2020.
Thomas J. Dietz
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is John Thomas Dietz's' Mailing Address?
- Mailing address is C/o Transcept Pharmaceutical, Inc. 1003 W. Cutting Blvd, Ste 110 Pt. Richmond CA 94804 CA
Eiger Biopharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| David A. Cory | 2020 | $590,584 | - | - | $829,564 | $393,360 | $16,671 | $1,830,179 |
| David A. Cory | 2019 | $565,833 | - | - | $2,009,820 | $285,000 | $11,200 | $2,871,853 |
| Sriram Ryali | 2020 | $381,550 | - | - | $234,442 | $173,272 | $12,296 | $801,559 |
| Sriram Ryali | 2019 | $335,000 | - | - | $662,211 | $117,250 | $9,732 | $1,124,193 |
| Eldon Mayer | 2020 | $385,569 | $100,000 | $92,700 | $1,199,520 | $169,256 | $2,328 | $1,949,373 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1305253/000119312521137193/d146195ddef14a.htm
What are Eiger Biopharmaceuticals, Inc's Past Insider Trades?
Eiger Biopharmaceuticals, Inc's most recent insider trade came on March 21, 2023 by Eldon C. Mayer III who sold 4,395 units worth $4.7K . In the last 7 years, insiders at Eiger Biopharmaceuticals, Inc have sold an estimated value of $3.06M and bought an estimated value of $4.81M worth of shares. Insider trading is most common in March, with the busiest year in 2019. The most active traders at the company are Thomas J. Dietz, Eldon C. Mayer III, Ex VP & Chief Commerc. Officer, and Jeffrey S Glenn .
Eiger BioPharmaceuticals, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||